Pontine norepinephrine defects in Mecp2-null mice involve deficient expression of dopamine β-hydroxylase but not a loss of catecholaminergic neurons

Biochemical and Biophysical Research Communications

Volumn 394, Issue 2, 2010, Pages 285-290

  Zhang, Xiaoli ^a   Su, Junda ^a   Rojas, Asheebo ^a   Jiang, Chun ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Catercholaminergic neurons; Dopamine hydroxylase; Norepinephrine; Rett syndrome; Tyrosine hydroxylase

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING DISORDER; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; IMMUNOCYTOCHEMISTRY; LOCUS CERULEUS; MALE; MECP2 GENE; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NUCLEOTIDE SEQUENCE; PLETHYSMOGRAPHY; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETT SYNDROME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CATECHOLAMINES; DOPAMINE BETA-HYDROXYLASE; FEMALE; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; NEURONS; NOREPINEPHRINE; PONS; RESPIRATORY SYSTEM ABNORMALITIES; RETT SYNDROME; TRANSCRIPTION, GENETIC; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 77950280301     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.156     Document Type: Article

References (24)

1. Francke U. Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat. Clin. Pract. Neurol. 2 (2006) 212-221
2. Chahrour M., and Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56 (2007) 422-437
3. Kerr A.M., Armstrong D.D., Prescott R.J., Doyle D., and Kearney D.L. Rett syndrome: analysis of deaths in the British survey. Eur. Child Adolesc. Psychiatry 6 Suppl. 1 (1997) 71-74
4. Julu P.O., Kerr A.M., Hansen S., Apartopoulos F., and Jamal G.A. Immaturity of medullary cardiorespiratory neurones leading to inappropriate autonomic reactions as a likely cause of sudden death in Rett's syndrome. Arch. Dis. Child. 77 (1997) 464-465
5. Guideri F., Acampa M., Hayek G., Zappella M., and Di Perri T. Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death. Neuropediatrics 30 (1999) 146-148
6. Weese-Mayer D.E., Lieske S.P., Boothby C.M., Kenny A.S., Bennett H.L., et al. Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr. Res. 60 (2006) 443-449
7. Guy J., Hendrich B., Holmes M., Martin J.E., and Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27 (2001) 322-326
8. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35 (2002) 243-254
9. Viemari J.C., Roux J.C., Tryba A.K., Saywell V., Burnet H., et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J. Neurosci. 25 (2005) 11521-11530
10. Ide S., Itoh M., and Goto Y. Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci. Lett. 386 (2005) 14-17
11. Samaco R.C., Mandel-Brehm C., Chao H.T., Ward C.S., Fyffe-Maricich S.L., et al. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc. Natl. Acad. Sci. USA 106 (2009) 21966-21971
12. Taneja P., Ogier M., Brooks-Harris G., Schmid D.A., Katz D.M., et al. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J. Neurosci. 29 (2009) 12187-12195
13. Zoghbi H.Y., Percy A.K., Glaze D.G., Butler I.J., and Riccardi V.M. Reduction of biogenic amine levels in the Rett syndrome. N. Engl. J. Med. 313 (1985) 921-924
14. Roux J.C., Dura E., Moncla A., Mancini J., and Villard L. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur. J. Neurosci. 25 (2007) 1915-1922
15. Zanella S., Mebarek S., Lajard A.M., Picard N., Dutschmann M., et al. Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model. Respir. Physiol. Neurobiol. 160 (2008) 116-121
16. J.C. Roux, N. Panayotis, E. Dura, L. Villard, Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice, J. Neurosci. Res. (in press).
17. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25 (2001) 402-408
18. -/y knockout mice. J. Physiol. 579 (2007) 863-876
19. Bissonnette J.M., and Knopp S.J. Effect of inspired oxygen on periodic breathing in methy-CpG-binding protein 2 (Mecp2) deficient mice. J. Appl. Physiol. 104 (2008) 198-204
20. Badoyannis H.C., Sharma S.C., and Sabban E.L. The differential effects of cell density and NGF on the expression of tyrosine hydroxylase and dopamine beta-hydroxylase in PC12 cells. Brain Res. Mol. Brain Res. 11 (1991) 79-87
21. Hirsch M.R., Tiveron M.C., Guillemot F., Brunet J.F., and Goridis C. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development 125 (1998) 599-608
22. Yasui D.H., Peddada S., Bieda M.C., Vallero R.O., Hogart A., et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl. Acad. Sci. USA 104 (2007) 19416-19421
23. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 (2003) 885-889
24. Guo H., Hellard D.T., Huang L., and Katz D.M. Development of pontine noradrenergic A5 neurons requires brain-derived neurotrophic factor. Eur. J. Neurosci. 21 (2005) 2019-2023